ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global FPR1 Inhibitor Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-14V17220
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global FPR1 Inhibitor Market Research Report 2024
BUY CHAPTERS

Global FPR1 Inhibitor Market Research Report 2025

Code: QYRE-Auto-14V17220
Report
September 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
R&D Systems
Abcam
ApexBio Technology
Bio-Techne
TargetMol Chemicals
Glpbio
MedChemexpress LLC
ProbeChem Biochemicals

FPR1 Inhibitor Market Size

The global market for FPR1 Inhibitor was valued at US$ 43.06 million in the year 2024 and is projected to reach a revised size of US$ 54.00 million by 2031, growing at a CAGR of 3.3% during the forecast period.

FPR1 Inhibitor Market

FPR1 Inhibitor Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on FPR1 Inhibitor competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, the global production of FPR1 inhibitors reached 3,076 grams, with an average selling price of US$14 per mg.
FPR1 inhibitor is a compound or substance used to inhibit the activity of FPR1 (Formyl Peptide Receptor 1, N-formyl peptide receptor 1). FPR1 is a G protein-coupled receptor that is involved in regulating biological processes such as inflammation, immunity, and cell migration. FPR1 inhibitors bind to FPR1 and block its signaling pathway, thereby inhibiting its related biological responses. These inhibitors are often used in scientific research to explore the role of FPR1 in physiological and pathological processes and may serve as potential drug targets for the development of disease treatments.
The FPR1 inhibitor market has shown a steady development trend in recent years. With in-depth research on the biological functions of FPR1 (Formyl Peptide Receptor 1), its key role in inflammatory response, cell migration, cancer development and other processes has been gradually revealed, which has promoted the development and application of FPR1 inhibitors. FPR1 inhibitors are mainly used in scientific research experiments, especially in drug discovery and mechanism research, playing an important role. They provide researchers with tools to regulate FPR1 function to gain insights into related physiological processes and develop novel treatments. In summary, the FPR1 inhibitor market has broad development prospects and huge market potential.

Report Scope

This report aims to provide a comprehensive presentation of the global market for FPR1 Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding FPR1 Inhibitor.
The FPR1 Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global FPR1 Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the FPR1 Inhibitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of FPR1 Inhibitor Market Report

Report Metric Details
Report Name FPR1 Inhibitor Market
Accounted market size in year US$ 43.06 million
Forecasted market size in 2031 US$ 54.00 million
CAGR 3.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • FPR1 Antagonists
  • Indirect Inhibitors
  • Antibody Blockers
  • Others
Segment by Application
  • Pharma/Biotech
  • Research
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Bio-Techne, Abcam, ApexBio Technology, TargetMol Chemicals, GLPBio, ProbeChem Biochemicals, MedChemExpress
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of FPR1 Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of FPR1 Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is FPR1 Inhibitor Market growing?

Ans: The FPR1 Inhibitor Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the FPR1 Inhibitor Market size in 2031?

Ans: The FPR1 Inhibitor Market size in 2031 will be US$ 54.00 million.

Who are the main players in the FPR1 Inhibitor Market report?

Ans: The main players in the FPR1 Inhibitor Market are Merck, Bio-Techne, Abcam, ApexBio Technology, TargetMol Chemicals, GLPBio, ProbeChem Biochemicals, MedChemExpress

What are the Application segmentation covered in the FPR1 Inhibitor Market report?

Ans: The Applications covered in the FPR1 Inhibitor Market report are Pharma/Biotech, Research, Other

What are the Type segmentation covered in the FPR1 Inhibitor Market report?

Ans: The Types covered in the FPR1 Inhibitor Market report are FPR1 Antagonists, Indirect Inhibitors, Antibody Blockers, Others

1 FPR1 Inhibitor Market Overview
1.1 Product Definition
1.2 FPR1 Inhibitor by Type
1.2.1 Global FPR1 Inhibitor Market Value Comparison by Type (2024 VS 2031)
1.2.2 FPR1 Antagonists
1.2.3 Indirect Inhibitors
1.2.4 Antibody Blockers
1.2.5 Others
1.3 FPR1 Inhibitor by Application
1.3.1 Global FPR1 Inhibitor Market Value by Application (2024 VS 2031)
1.3.2 Pharma/Biotech
1.3.3 Research
1.3.4 Other
1.4 Global FPR1 Inhibitor Market Size Estimates and Forecasts
1.4.1 Global FPR1 Inhibitor Revenue 2020-2031
1.4.2 Global FPR1 Inhibitor Sales 2020-2031
1.4.3 Global FPR1 Inhibitor Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 FPR1 Inhibitor Market Competition by Manufacturers
2.1 Global FPR1 Inhibitor Sales Market Share by Manufacturers (2020-2025)
2.2 Global FPR1 Inhibitor Revenue Market Share by Manufacturers (2020-2025)
2.3 Global FPR1 Inhibitor Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of FPR1 Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of FPR1 Inhibitor, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of FPR1 Inhibitor, Product Type & Application
2.7 Global Key Manufacturers of FPR1 Inhibitor, Date of Enter into This Industry
2.8 Global FPR1 Inhibitor Market Competitive Situation and Trends
2.8.1 Global FPR1 Inhibitor Market Concentration Rate
2.8.2 The Global 5 and 10 Largest FPR1 Inhibitor Players Market Share by Revenue
2.8.3 Global FPR1 Inhibitor Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global FPR1 Inhibitor Market Scenario by Region
3.1 Global FPR1 Inhibitor Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global FPR1 Inhibitor Sales by Region: 2020-2031
3.2.1 Global FPR1 Inhibitor Sales by Region: 2020-2025
3.2.2 Global FPR1 Inhibitor Sales by Region: 2026-2031
3.3 Global FPR1 Inhibitor Revenue by Region: 2020-2031
3.3.1 Global FPR1 Inhibitor Revenue by Region: 2020-2025
3.3.2 Global FPR1 Inhibitor Revenue by Region: 2026-2031
3.4 North America FPR1 Inhibitor Market Facts & Figures by Country
3.4.1 North America FPR1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America FPR1 Inhibitor Sales by Country (2020-2031)
3.4.3 North America FPR1 Inhibitor Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe FPR1 Inhibitor Market Facts & Figures by Country
3.5.1 Europe FPR1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe FPR1 Inhibitor Sales by Country (2020-2031)
3.5.3 Europe FPR1 Inhibitor Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific FPR1 Inhibitor Market Facts & Figures by Region
3.6.1 Asia Pacific FPR1 Inhibitor Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific FPR1 Inhibitor Sales by Region (2020-2031)
3.6.3 Asia Pacific FPR1 Inhibitor Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America FPR1 Inhibitor Market Facts & Figures by Country
3.7.1 Latin America FPR1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America FPR1 Inhibitor Sales by Country (2020-2031)
3.7.3 Latin America FPR1 Inhibitor Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa FPR1 Inhibitor Market Facts & Figures by Country
3.8.1 Middle East and Africa FPR1 Inhibitor Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa FPR1 Inhibitor Sales by Country (2020-2031)
3.8.3 Middle East and Africa FPR1 Inhibitor Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global FPR1 Inhibitor Sales by Type (2020-2031)
4.1.1 Global FPR1 Inhibitor Sales by Type (2020-2025)
4.1.2 Global FPR1 Inhibitor Sales by Type (2026-2031)
4.1.3 Global FPR1 Inhibitor Sales Market Share by Type (2020-2031)
4.2 Global FPR1 Inhibitor Revenue by Type (2020-2031)
4.2.1 Global FPR1 Inhibitor Revenue by Type (2020-2025)
4.2.2 Global FPR1 Inhibitor Revenue by Type (2026-2031)
4.2.3 Global FPR1 Inhibitor Revenue Market Share by Type (2020-2031)
4.3 Global FPR1 Inhibitor Price by Type (2020-2031)
5 Segment by Application
5.1 Global FPR1 Inhibitor Sales by Application (2020-2031)
5.1.1 Global FPR1 Inhibitor Sales by Application (2020-2025)
5.1.2 Global FPR1 Inhibitor Sales by Application (2026-2031)
5.1.3 Global FPR1 Inhibitor Sales Market Share by Application (2020-2031)
5.2 Global FPR1 Inhibitor Revenue by Application (2020-2031)
5.2.1 Global FPR1 Inhibitor Revenue by Application (2020-2025)
5.2.2 Global FPR1 Inhibitor Revenue by Application (2026-2031)
5.2.3 Global FPR1 Inhibitor Revenue Market Share by Application (2020-2031)
5.3 Global FPR1 Inhibitor Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck FPR1 Inhibitor Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Bio-Techne
6.2.1 Bio-Techne Company Information
6.2.2 Bio-Techne Description and Business Overview
6.2.3 Bio-Techne FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bio-Techne FPR1 Inhibitor Product Portfolio
6.2.5 Bio-Techne Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abcam FPR1 Inhibitor Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 ApexBio Technology
6.4.1 ApexBio Technology Company Information
6.4.2 ApexBio Technology Description and Business Overview
6.4.3 ApexBio Technology FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.4.4 ApexBio Technology FPR1 Inhibitor Product Portfolio
6.4.5 ApexBio Technology Recent Developments/Updates
6.5 TargetMol Chemicals
6.5.1 TargetMol Chemicals Company Information
6.5.2 TargetMol Chemicals Description and Business Overview
6.5.3 TargetMol Chemicals FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.5.4 TargetMol Chemicals FPR1 Inhibitor Product Portfolio
6.5.5 TargetMol Chemicals Recent Developments/Updates
6.6 GLPBio
6.6.1 GLPBio Company Information
6.6.2 GLPBio Description and Business Overview
6.6.3 GLPBio FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GLPBio FPR1 Inhibitor Product Portfolio
6.6.5 GLPBio Recent Developments/Updates
6.7 ProbeChem Biochemicals
6.7.1 ProbeChem Biochemicals Company Information
6.7.2 ProbeChem Biochemicals Description and Business Overview
6.7.3 ProbeChem Biochemicals FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ProbeChem Biochemicals FPR1 Inhibitor Product Portfolio
6.7.5 ProbeChem Biochemicals Recent Developments/Updates
6.8 MedChemExpress
6.8.1 MedChemExpress Company Information
6.8.2 MedChemExpress Description and Business Overview
6.8.3 MedChemExpress FPR1 Inhibitor Sales, Revenue and Gross Margin (2020-2025)
6.8.4 MedChemExpress FPR1 Inhibitor Product Portfolio
6.8.5 MedChemExpress Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 FPR1 Inhibitor Industry Chain Analysis
7.2 FPR1 Inhibitor Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 FPR1 Inhibitor Production Mode & Process Analysis
7.4 FPR1 Inhibitor Sales and Marketing
7.4.1 FPR1 Inhibitor Sales Channels
7.4.2 FPR1 Inhibitor Distributors
7.5 FPR1 Inhibitor Customer Analysis
8 FPR1 Inhibitor Market Dynamics
8.1 FPR1 Inhibitor Industry Trends
8.2 FPR1 Inhibitor Market Drivers
8.3 FPR1 Inhibitor Market Challenges
8.4 FPR1 Inhibitor Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
R&D Systems
Abcam
ApexBio Technology
Bio-Techne
TargetMol Chemicals
Glpbio
MedChemexpress LLC
ProbeChem Biochemicals
List of Tables
 Table 1. Global FPR1 Inhibitor Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global FPR1 Inhibitor Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global FPR1 Inhibitor Market Competitive Situation by Manufacturers in 2024
 Table 4. Global FPR1 Inhibitor Sales (g) of Key Manufacturers (2020-2025)
 Table 5. Global FPR1 Inhibitor Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global FPR1 Inhibitor Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global FPR1 Inhibitor Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market FPR1 Inhibitor Average Price (US$/mg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of FPR1 Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of FPR1 Inhibitor, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of FPR1 Inhibitor, Product Type & Application
 Table 12. Global Key Manufacturers of FPR1 Inhibitor, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global FPR1 Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in FPR1 Inhibitor as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global FPR1 Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global FPR1 Inhibitor Sales by Region (2020-2025) & (g)
 Table 18. Global FPR1 Inhibitor Sales Market Share by Region (2020-2025)
 Table 19. Global FPR1 Inhibitor Sales by Region (2026-2031) & (g)
 Table 20. Global FPR1 Inhibitor Sales Market Share by Region (2026-2031)
 Table 21. Global FPR1 Inhibitor Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global FPR1 Inhibitor Revenue Market Share by Region (2020-2025)
 Table 23. Global FPR1 Inhibitor Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global FPR1 Inhibitor Revenue Market Share by Region (2026-2031)
 Table 25. North America FPR1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America FPR1 Inhibitor Sales by Country (2020-2025) & (g)
 Table 27. North America FPR1 Inhibitor Sales by Country (2026-2031) & (g)
 Table 28. North America FPR1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America FPR1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe FPR1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe FPR1 Inhibitor Sales by Country (2020-2025) & (g)
 Table 32. Europe FPR1 Inhibitor Sales by Country (2026-2031) & (g)
 Table 33. Europe FPR1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe FPR1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific FPR1 Inhibitor Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific FPR1 Inhibitor Sales by Region (2020-2025) & (g)
 Table 37. Asia Pacific FPR1 Inhibitor Sales by Region (2026-2031) & (g)
 Table 38. Asia Pacific FPR1 Inhibitor Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific FPR1 Inhibitor Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America FPR1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America FPR1 Inhibitor Sales by Country (2020-2025) & (g)
 Table 42. Latin America FPR1 Inhibitor Sales by Country (2026-2031) & (g)
 Table 43. Latin America FPR1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America FPR1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa FPR1 Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa FPR1 Inhibitor Sales by Country (2020-2025) & (g)
 Table 47. Middle East and Africa FPR1 Inhibitor Sales by Country (2026-2031) & (g)
 Table 48. Middle East and Africa FPR1 Inhibitor Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa FPR1 Inhibitor Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global FPR1 Inhibitor Sales (g) by Type (2020-2025)
 Table 51. Global FPR1 Inhibitor Sales (g) by Type (2026-2031)
 Table 52. Global FPR1 Inhibitor Sales Market Share by Type (2020-2025)
 Table 53. Global FPR1 Inhibitor Sales Market Share by Type (2026-2031)
 Table 54. Global FPR1 Inhibitor Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global FPR1 Inhibitor Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global FPR1 Inhibitor Revenue Market Share by Type (2020-2025)
 Table 57. Global FPR1 Inhibitor Revenue Market Share by Type (2026-2031)
 Table 58. Global FPR1 Inhibitor Price (US$/mg) by Type (2020-2025)
 Table 59. Global FPR1 Inhibitor Price (US$/mg) by Type (2026-2031)
 Table 60. Global FPR1 Inhibitor Sales (g) by Application (2020-2025)
 Table 61. Global FPR1 Inhibitor Sales (g) by Application (2026-2031)
 Table 62. Global FPR1 Inhibitor Sales Market Share by Application (2020-2025)
 Table 63. Global FPR1 Inhibitor Sales Market Share by Application (2026-2031)
 Table 64. Global FPR1 Inhibitor Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global FPR1 Inhibitor Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global FPR1 Inhibitor Revenue Market Share by Application (2020-2025)
 Table 67. Global FPR1 Inhibitor Revenue Market Share by Application (2026-2031)
 Table 68. Global FPR1 Inhibitor Price (US$/mg) by Application (2020-2025)
 Table 69. Global FPR1 Inhibitor Price (US$/mg) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 73. Merck FPR1 Inhibitor Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Bio-Techne Company Information
 Table 76. Bio-Techne Description and Business Overview
 Table 77. Bio-Techne FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 78. Bio-Techne FPR1 Inhibitor Product
 Table 79. Bio-Techne Recent Developments/Updates
 Table 80. Abcam Company Information
 Table 81. Abcam Description and Business Overview
 Table 82. Abcam FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 83. Abcam FPR1 Inhibitor Product
 Table 84. Abcam Recent Developments/Updates
 Table 85. ApexBio Technology Company Information
 Table 86. ApexBio Technology Description and Business Overview
 Table 87. ApexBio Technology FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 88. ApexBio Technology FPR1 Inhibitor Product
 Table 89. ApexBio Technology Recent Developments/Updates
 Table 90. TargetMol Chemicals Company Information
 Table 91. TargetMol Chemicals Description and Business Overview
 Table 92. TargetMol Chemicals FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 93. TargetMol Chemicals FPR1 Inhibitor Product
 Table 94. TargetMol Chemicals Recent Developments/Updates
 Table 95. GLPBio Company Information
 Table 96. GLPBio Description and Business Overview
 Table 97. GLPBio FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 98. GLPBio FPR1 Inhibitor Product
 Table 99. GLPBio Recent Developments/Updates
 Table 100. ProbeChem Biochemicals Company Information
 Table 101. ProbeChem Biochemicals Description and Business Overview
 Table 102. ProbeChem Biochemicals FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 103. ProbeChem Biochemicals FPR1 Inhibitor Product
 Table 104. ProbeChem Biochemicals Recent Developments/Updates
 Table 105. MedChemExpress Company Information
 Table 106. MedChemExpress Description and Business Overview
 Table 107. MedChemExpress FPR1 Inhibitor Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)
 Table 108. MedChemExpress FPR1 Inhibitor Product
 Table 109. MedChemExpress Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. FPR1 Inhibitor Distributors List
 Table 113. FPR1 Inhibitor Customers List
 Table 114. FPR1 Inhibitor Market Trends
 Table 115. FPR1 Inhibitor Market Drivers
 Table 116. FPR1 Inhibitor Market Challenges
 Table 117. FPR1 Inhibitor Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of FPR1 Inhibitor
 Figure 2. Global FPR1 Inhibitor Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global FPR1 Inhibitor Market Share by Type: 2024 & 2031
 Figure 4. FPR1 Antagonists Product Picture
 Figure 5. Indirect Inhibitors Product Picture
 Figure 6. Antibody Blockers Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global FPR1 Inhibitor Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global FPR1 Inhibitor Market Share by Application: 2024 & 2031
 Figure 10. Pharma/Biotech
 Figure 11. Research
 Figure 12. Other
 Figure 13. Global FPR1 Inhibitor Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global FPR1 Inhibitor Market Size (2020-2031) & (US$ Million)
 Figure 15. Global FPR1 Inhibitor Sales (2020-2031) & (g)
 Figure 16. Global FPR1 Inhibitor Average Price (US$/mg) & (2020-2031)
 Figure 17. FPR1 Inhibitor Report Years Considered
 Figure 18. FPR1 Inhibitor Sales Share by Manufacturers in 2024
 Figure 19. Global FPR1 Inhibitor Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest FPR1 Inhibitor Players: Market Share by Revenue in FPR1 Inhibitor in 2024
 Figure 21. FPR1 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global FPR1 Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America FPR1 Inhibitor Sales Market Share by Country (2020-2031)
 Figure 24. North America FPR1 Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 25. United States FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe FPR1 Inhibitor Sales Market Share by Country (2020-2031)
 Figure 28. Europe FPR1 Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 29. Germany FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific FPR1 Inhibitor Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific FPR1 Inhibitor Revenue Market Share by Region (2020-2031)
 Figure 36. China FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America FPR1 Inhibitor Sales Market Share by Country (2020-2031)
 Figure 44. Latin America FPR1 Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Colombia FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa FPR1 Inhibitor Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa FPR1 Inhibitor Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE FPR1 Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of FPR1 Inhibitor by Type (2020-2031)
 Figure 55. Global Revenue Market Share of FPR1 Inhibitor by Type (2020-2031)
 Figure 56. Global FPR1 Inhibitor Price (US$/mg) by Type (2020-2031)
 Figure 57. Global Sales Market Share of FPR1 Inhibitor by Application (2020-2031)
 Figure 58. Global Revenue Market Share of FPR1 Inhibitor by Application (2020-2031)
 Figure 59. Global FPR1 Inhibitor Price (US$/mg) by Application (2020-2031)
 Figure 60. FPR1 Inhibitor Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global FPR1 Activator Market Research Report 2024
Global FPR1 Antibody Market Research Report 2024
Global Pan FGFR Inhibitors Market Research Report 2024
Global Angiotensin II Type 1 Receptor AT1R Antagonists Market Research Report 2024
Global GLP 1 Receptor Antagonist Market Research Report 2024
Global GIP 1 Receptor Agonist Market Research Report 2024
Global N Formyl Peptide Market Research Report 2024
Fibroblast Growth Factor Receptor 2 Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AT1 Receptor Antagonists Market Research Report 2024
Global Sphingosine 1 Phosphate Receptor S1PR Modulator Market Research Report 2024
Fibroblast Activation Protein Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global IL 6R Inhibitor Market Research Report 2024
Global Sphingosine 1 Phosphate Receptor 1 Market Insights Forecast to 2030
Global GLP 1 Receptor Agonist Drugs Market Research Report 2024
Global SFRP1 ELISA Kits Market Research Report 2024
Global S1P Receptor Modulator Drugs Market Research Report 2025
Global Cathepsin Inhibitors Market Research Report 2024
Global Neurokinin Receptor Antagonists API Market Research Report 2024
Global FOLR1 ELISA Kits Market Research Report 2024
Global IL 2R Inhibitors Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions